financetom
Business
financetom
/
Business
/
Trump says plan will cut medicine costs by 100% or more
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump says plan will cut medicine costs by 100% or more
Sep 30, 2025 9:07 AM

WASHINGTON, Sept 30 (Reuters) - U.S. President Donald

Trump on Tuesday said his administration would cut drug prices

by a 100% or more, speaking ahead of a planned announcement with

Pfizer ( PFE ) on lower prices for several medications, without

explaining how the cuts would be enacted.

"I think it's one of the biggest things that we'll do. We'll

be reducing drug prices by 100% in some cases, 300% or more," he

told reporters as he arrived at the White House after delivering

remarks to the military in Virginia.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DoorDash, OpenAI Partner to Offer Grocery Shopping App Inside ChatGPT
DoorDash, OpenAI Partner to Offer Grocery Shopping App Inside ChatGPT
Mar 10, 2026
05:47 PM EST, 12/17/2025 (MT Newswires) -- DoorDash ( DASH ) has teamed up with Microsoft ( MSFT )-backed OpenAI (MSFT) to offer a grocery-shopping app directly within ChatGPT, allowing users to convert recipes into food orders delivered from nearby stores. The partnership marks a shift toward agentic commerce, with AI acting as a personal assistant to handle shopping, payments,...
BP Appoints Meg O'Neill as Chief Executive Officer
BP Appoints Meg O'Neill as Chief Executive Officer
Mar 10, 2026
05:54 PM EST, 12/17/2025 (MT Newswires) -- BP (BP) said late Wednesday it appointed Meg O'Neill as chief executive officer, starting April 1, 2026. O'Neill will succeed Murray Auchincloss, who will step down as CEO and board director on Dec. 18. Auchincloss will continue in an advisory role until December 2026 to support the transition. Carol Howle, executive vice president...
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Mar 10, 2026
05:50 PM EST, 12/17/2025 (MT Newswires) -- Kalaris Therapeutics ( KLRS ) reported late Wednesday positive initial data from its Phase 1a trial of its investigational drug for treating naive neovascular AMD patients. The single ascending dose (SAD) trial showed the drug candidate, TH103, had clinically meaningful improvements in vision and retinal anatomy. The trial also indicated early signs of...
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
Mar 10, 2026
05:47 PM EST, 12/17/2025 (MT Newswires) -- Marshall Urist, Executive Vice President, Research & Investments, on December 16, 2025, sold 20,000 shares in Royalty Pharma ( RPRX ) for $766,420. Following the Form 4 filing with the SEC, Urist has control over a total of 166,418 Class A ordinary shares of the company, with 7,398 shares held directly and 159,020...
Copyright 2023-2026 - www.financetom.com All Rights Reserved